New 3D Technology Can Repair Aneurysms Previously Deemed Inoperable
New technology from Cydar is allowing UC San Diego Health surgeons to repair aneurysms previously deemed inoperable.
New technology from Cydar is allowing UC San Diego Health surgeons to repair aneurysms previously deemed inoperable.
An international team of researchers has discovered a cause for a rare eye disease affecting the macula that leads to loss of central vision, called macular telangiectasia type 2 (MacTel).
Researchers at Scripps Institution of Oceanography at the University of California San Diego and the University of California Berkeley have discovered a new method of communication in the Atlantic ghost crab, Ocypode quadrata.
Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
UC San Diego researchers say that measuring how quickly a person’s pupil dilates while they are taking cognitive tests may be a low-cost, low-invasive method to aid in screening individuals at increased genetic risk for AD before cognitive decline begins.
Bioengineers and biologists at the University of California San Diego have developed a method to significantly extend the life of gene circuits used to instruct microbes to do things such as produce and deliver drugs, break down chemicals and serve as environmental sensors.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.